Slassi; Abdelmalik

Patent Applications and Registrations

Patent applications and USPTO patent grants for Slassi; Abdelmalik.The latest application filed is for "psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders".

Company Profile

5.44.98

Slassi; Abdelmalik - Mississauga CA
Slassi; Abdelmalik - Ontario N/A CA
Slassi; Abdelmalik - Toronto CA
Slassi; Abdelmalik - Mississauge CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders Grant 11,453,689 - Slassi , et al. September 27, 2	2022-09-27
Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220289774 - Slassi; Abdelmalik ; et al.	2022-09-15
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders Grant 11,427,604 - Slassi , et al. August 30, 2	2022-08-30
Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220024956 - Slassi; Abdelmalik ; et al.	2022-01-27
3-pyrrolidine-indole Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220017550 - Slassi; Abdelmalik ; et al.	2022-01-20
Psilocin Derivatives As Serotonergic Psychedelic Agents For The Treatment Of Cns Disorders App 20220017549 - Slassi; Abdelmalik ; et al.	2022-01-20
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins Grant 10,696,670 - Slassi , et al. June 30, 2	2020-06-30
Fluorinated Amide Derivatives And Their Uses As Therapeutic Agents App 20200181067 - Slassi; Abdelmalik	2020-06-11
Fluorinated amide derivatives and their uses as therapeutic agents Grant 10,604,476 - Slassi	2020-03-31
Heteroaromatic-fused Imidazolyl Amides, Compositions And Uses Thereof As Sting Agonists App 20200031825 - Slassi; Abdelmalik ; et al.	2020-01-30
Heterocycle Derivatives And Their Use For The Treatment Of Cns Disorders App 20190367466 - Slassi; Abdelmalik	2019-12-05
Heterocycle derivatives and their use for the treatment of CNS disorders Grant 10,428,030 - Slassi October 1, 2	2019-10-01
Fluorinated Imidazo[4,5-c]quinoline Derivatives As Inhibitors Of Bromodomain Containing Proteins App 20190202825 - Slassi; Abdelmalik ; et al.	2019-07-04
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins Grant 10,259,809 - Slassi , et al.	2019-04-16
Novel Fluorinated Quinazoline Derivatives As Egfr Inhibitors App 20190016689 - Slassi; Abdelmalik ; et al.	2019-01-17
Fluorinated Amide Derivatives And Their Uses As Therapeutic Agents App 20180334425 - SLASSI; Abdelmalik	2018-11-22
Heterocycle Derivatives And Their Use For The Treatment Of Cns Disorders App 20180312480 - Slassi; Abdelmalik	2018-11-01
Novel Fluorinated Derivatives As Egfr Inhibitors Useful For Treating Cancers App 20180050993 - Slassi; Abdelmalik ; et al.	2018-02-22
Process For The Synthesis Of Difluoromethyl Ether-based Compounds App 20180016227 - Slassi; Abdelmalik ; et al.	2018-01-18
Fluorinated Imidazo[4,5-c]quinoline Derivatives As Inhibitors Of Bromodomain Containing Proteins App 20180016271 - Slassi; Abdelmalik ; et al.	2018-01-18
Fluorinated Epoxyketone-based Compounds And Uses Thereof As Proteasome Inhibitors App 20160347792 - Slassi; Abdelmalik ; et al.	2016-12-01
Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors Grant 9,441,012 - Slassi , et al. September 13, 2	2016-09-13
Fluorinated Epoxyketone-based Tetrapeptide Compounds And Uses Thereof As Proteasome Inhibitors App 20150218212 - Slassi; Abdelmalik ; et al.	2015-08-06
Fluorinated Epoxyketone-based Compounds And Uses Thereof As Proteasome Inhibitors App 20150203534 - Slassi; Abdelmalik ; et al.	2015-07-23
Use Of D-serine Derivatives For The Treatment Of Anxiety Disorders App 20140018549 - Higgins; Guy ; et al.	2014-01-16
Use of D-serine derivatives for the treatment of anxiety disorders Grant 8,450,336 - Higgins , et al. May 28, 2	2013-05-28
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 Grant 8,377,939 - Clayton , et al. February 19, 2	2013-02-19
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators--842 Grant 8,377,940 - Clayton , et al. February 19, 2	2013-02-19
Azaindoles Having Serotonin Receptor Affinity App 20120302596 - Edwards; Louise ; et al.	2012-11-29
Metabotropic glutamate-receptor-potentiating isoindolones Grant 8,153,638 - Van Wagenen , et al. April 10, 2	2012-04-10
Azaindoles having serotonin receptor affinity Grant 8,148,394 - Edwards , et al. April 3, 2	2012-04-03
Treatment Of Muscle Disease Characterized By Insulin Resistance App 20120065176 - Megeney; Lynn ; et al.	2012-03-15
Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators App 20110166155 - VAN WAGENEN; Bradford ; et al.	2011-07-07
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,968,570 - Clayton , et al. June 28, 2	2011-06-28
Pharmaceutically active compounds containing tetrazolyl and triazolyl rings Grant 7,960,422 - Arzel , et al. June 14, 2	2011-06-14
Piperazines and piperidines as Mglur5 potentiators Grant 7,935,703 - Slassi , et al. May 3, 2	2011-05-03
Fluorinated compounds Grant 7,902,401 - Higgins , et al. March 8, 2	2011-03-08
AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613 App 20110053953 - Slassi; Abdelmalik ; et al.	2011-03-03
Substituted isoindolones and their use as metabotropic glutamate receptor potentiators Grant 7,868,008 - Van Wagenen , et al. January 11, 2	2011-01-11
Metabotropic Glutamate-Receptor-Potentiating Isoindolones App 20100317674 - Van Wagenen; Bradford ; et al.	2010-12-16
Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators App 20100280082 - Clayton; Joshua ; et al.	2010-11-04
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842 App 20100267740 - Clayton; Joshua ; et al.	2010-10-21
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,816,354 - Slassi , et al. October 19, 2	2010-10-19
Metabotropic glutamate-receptor-potentiating isoindolones Grant 7,807,706 - Van Wagenen , et al. October 5, 2	2010-10-05
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841 Grant 7,799,792 - Clayton , et al. September 21, 2	2010-09-21
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,790,717 - Egle , et al. September 7, 2	2010-09-07
mGluR5 modulators Grant 7,772,235 - Isaac , et al. August 10, 2	2010-08-10
Piperazine and Piperidine MGLUR5 Potentiators App 20100144710 - Arora; Jalaj ; et al.	2010-06-10
Tetrazole compounds and their use as metabotropic glutamate receptor antagonists Grant 7,691,892 - Johansson , et al. April 6, 2	2010-04-06
MGluR5 modulators I Grant 7,678,796 - Wallberg , et al. March 16, 2	2010-03-16
Use Of D-serine Derivatives For The Treatment Of Anxiety Disorders App 20100016403 - Higgins; Guy ; et al.	2010-01-21
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators App 20090275578 - Clayton; Joshua ; et al.	2009-11-05
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists Grant 7,585,881 - Edwards , et al. September 8, 2	2009-09-08
Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists Grant 7,576,077 - Wensbo , et al. August 18, 2	2009-08-18
Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators App 20090192169 - Egle; Ian ; et al.	2009-07-30
Metabotropic Glutamate Receptor-Potentiating Isoindolones App 20090149505 - Empfield; James R. ; et al.	2009-06-11
New compounds 067 App 20090131454 - Arzel; Erwan ; et al.	2009-05-21
Spiro-oxazolidinone Compounds And Their Use As Metabotropic Glutamate Receptor Potentiators App 20090124578 - EGLE; Ian ; et al.	2009-05-14
Substituted Isoindolones And Their Use As Metabotropic Glutamate Receptor Potentiators App 20090111830 - Wagenen; Bradford Van ; et al.	2009-04-30
1,2,4-triazole Carboxylic Acid Derivatives As Modulators Of Mglur5 App 20090111811 - GRANBERG; Kenneth ; et al.	2009-04-30
Amide Linked Heteroaromatic Derivatives As Modulators Of Mglur5 App 20090111824 - Bratt; Emma ; et al.	2009-04-30
1,2,4-triazole Ether Derivatives As Modulators Of Mglur5 App 20090111857 - DOVE; Peter ; et al.	2009-04-30
Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders App 20090069340 - Balestra; Michael ; et al.	2009-03-12
Use App 20090054491 - Edwards; Louise ; et al.	2009-02-26
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators Grant 7,485,722 - Egle , et al. February 3, 2	2009-02-03
Piperazines and Piperidines as Mglur5 Potentiators App 20090023711 - Slassi; Abdelmalik ; et al.	2009-01-22
Compounds for the treatment of neurological, psychiatric or pain disorders Grant 7,476,684 - Minidis , et al. January 13, 2	2009-01-13
Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators App 20090012089 - Slassi; Abdelmalik ; et al.	2009-01-08
Fluorinated Compounds App 20090005433 - Higgins; Guy A ; et al.	2009-01-01
Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor Modulators App 20080318999 - Isaac; Methvin ; et al.	2008-12-25
Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists App 20080312240 - Edwards; Louise ; et al.	2008-12-18
Substituted Piperazines as Metabotropic Glutamate Receptor Antagonists App 20080312246 - Edwards; Louise ; et al.	2008-12-18
Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators 841 App 20080306088 - Clayton; Joshua ; et al.	2008-12-11
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators 842 App 20080306077 - Clayton; Joshua ; et al.	2008-12-11
Compounds Grant 7,456,200 - Arora , et al. November 25, 2	2008-11-25
Metabotropic Glutamate-Receptor-Potentiating Isoindolones App 20080227794 - Van Wagenen; Bradford ; et al.	2008-09-18
5-(Phenylisoxazolylethoxy) - Triazol- 3 -Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders App 20080227824 - Minidis; Alexander ; et al.	2008-09-18
Acetylenic Piperazines as Metabotropic Glutamate Receptor Antagonists App 20080194571 - Edwards; Louise ; et al.	2008-08-14
MgluR5 modulators App 20080125436 - Isaac; Methvin ; et al.	2008-05-29
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators App 20080125431 - Egle; Ian ; et al.	2008-05-29
Additional Heteropolycyclic Compounds And Their Use As Metabotropic Glutamate Receptor Antagonists App 20080045571 - Edwards; Louise ; et al.	2008-02-21
Additional Heteropolycyclic Compounds And Their Use As Metabotropic Glutamate Receptor Antagonists App 20080015204 - Edwards; Louise ; et al.	2008-01-17
Additional Heteropolycyclic Compounds And Their Use As Metabotropic Glutamate Receptor Antagonists App 20080015234 - Edwards; Louise ; et al.	2008-01-17
Azaindoles Having Serotonin Receptor Affinity App 20080004307 - Edwards; Louise ; et al.	2008-01-03
Additional Heteropolycyclic Compounds And Their Use As Metabotropic Glutamate Receptor Antagonists App 20070293545 - Edwards; Louise ; et al.	2007-12-20
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators App 20070275966 - Slassi; Abdelmalik ; et al.	2007-11-29
New Compounds For The Treatment Of Neurological, Psychiatric Or Pain Disorders App 20070270469 - MINIDIS; Alexander ; et al.	2007-11-22
New Compounds For The Treatment Of Neurological, Psychiatric Or Pain Disorders App 20070270468 - MINIDIS; Alexander ; et al.	2007-11-22
mGluR5 modulators III App 20070259926 - Isaac; Methvin ; et al.	2007-11-08
mGluR5 modulators II App 20070259916 - Isaac; Methvin ; et al.	2007-11-08
MGluR5 modulators V App 20070259860 - Wallberg; Andreas ; et al.	2007-11-08
MGluR5 modulators I App 20070259862 - Wallberg; Andreas ; et al.	2007-11-08
MGluR5 modulators VI App 20070259895 - Isaac; Methvin ; et al.	2007-11-08
MGluR5 modulators IV App 20070259923 - Isaac; Methvin ; et al.	2007-11-08
5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5 App 20070255061 - Wensbo; David ; et al.	2007-11-01
Azaindoles having serotonin receptor affinity Grant 7,268,127 - Edwards , et al. September 11, 2	2007-09-11
Tetrazole compounds and their use as metabotropic glutamate receptor antagonists App 20070197549 - Johansson; Martin ; et al.	2007-08-23
Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists App 20070185095 - Johansson; Martin ; et al.	2007-08-09
Triazole compounds and their use as metabotropic glutamate receptor antagonists App 20070185178 - Edwards; Louise ; et al.	2007-08-09
Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists App 20070185100 - Arora; Jalaj ; et al.	2007-08-09
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20070179188 - Edwards; Louise ; et al.	2007-08-02
New compounds for the treatment of neurological, psychiatric or pain disorders App 20070129408 - Minidis; Alexander ; et al.	2007-06-07
Cinnamamide compounds as metabotropic glutamate receptor antagonists App 20070049578 - Edwards; Louise ; et al.	2007-03-01
Substituted piperazines as metabotropic glutamate receptor antagonists App 20070037820 - Edwards; Louise ; et al.	2007-02-15
Bicyclic piperazines as metabotropic glutatmate receptor antagonists App 20070037816 - Edwards; Louise ; et al.	2007-02-15
Acetylenic piperazines as metabotropic glutamate receptor antagonists App 20070037817 - Edwards; Louise ; et al.	2007-02-15
Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators App 20070032469 - Isaac; Methvin ; et al.	2007-02-08
Therapeutic compounds App 20070021606 - Egle; Ian ; et al.	2007-01-25
Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists App 20060235024 - Bryan; Chris ; et al.	2006-10-19
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists Grant 7,112,595 - Wagenen , et al. September 26, 2	2006-09-26
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20060189661 - Wagenen; Bradford Van ; et al.	2006-08-24
Compounds Grant 7,074,809 - Arora , et al. July 11, 2	2006-07-11
Compounds App 20060122397 - Arora; Jalaj ; et al.	2006-06-08
New compounds App 20060063772 - Arora; Jalaj ; et al.	2006-03-23
Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists App 20060025414 - Arora; Jalaj ; et al.	2006-02-02
Triazole compounds and their use as metabotropic glutamate receptor antagonists App 20060019997 - Edwards; Louise ; et al.	2006-01-26
Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists App 20060009443 - Wensbo; David ; et al.	2006-01-12
Tetrazole compounds and their use as metabotropic glutamate receptor antagonists App 20060004021 - Johansson; Martin ; et al.	2006-01-05
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20050272779 - Edwards, Louise ; et al.	2005-12-08
Azaindoles having serotonin receptor affinity App 20050239788 - Edwards, Louise ; et al.	2005-10-27
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20050154027 - Wagenen, Bradford Van ; et al.	2005-07-14
Azaindoles having serotonin receptor affinity Grant 6,916,818 - Edwards , et al. July 12, 2	2005-07-12
Compounds having 5-HT6 receptor antagonist activity Grant 6,897,215 - Xin , et al. May 24, 2	2005-05-24
Heterocyclic compounds for the treatment of migraine App 20040167158 - Edwards, Louise ; et al.	2004-08-26
Arylglycine derivatives and their use as glycine transport inhibitors App 20040152741 - Isaac, Methvin ; et al.	2004-08-05
Compounds App 20040152699 - Arora, Jalaj ; et al.	2004-08-05
Arylglycine derivatives for use as glycine transport inhibitors App 20040152740 - Isaac, Methvin ; et al.	2004-08-05
New compounds App 20040132726 - Arora, Jalaj ; et al.	2004-07-08
Azaindoles having serotonin receptor affinity App 20040132734 - Edwards, Louise ; et al.	2004-07-08
New compounds App 20040106607 - Arora, Jalaj ; et al.	2004-06-03
Heterocyclic compounds for the treatment of migraine Grant 6,716,837 - Edwards , et al. April 6, 2	2004-04-06
Azaindoles having serotonin receptor affinity Grant 6,686,374 - Edwards , et al. February 3, 2	2004-02-03
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists Grant 6,660,753 - Van Wagenen , et al. December 9, 2	2003-12-09
Use of N-alkylamino-heterocylic compounds for the treatment of migraine Grant 6,635,639 - Arora , et al. October 21, 2	2003-10-21
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20030055085 - Wagenen, Bradford Van ; et al.	2003-03-20
Azaindoles having serotonin receptor affnity App 20010049441 - Edwards, Louise ; et al.	2001-12-06
Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity Grant 6,251,893 - Maddaford , et al. June 26, 2	2001-06-26
Pyrrolidine-indole compounds having 5-HT.sub.6 affinity Grant 6,100,291 - Slassi , et al. August 8, 2	2000-08-08
5-cyclo indole compounds Grant 5,998,438 - Slassi , et al. December 7, 1	1999-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.